Investing.com - UnitedHealth Group (NYSE:UNH) faces risks to earnings growth despite a recent leadership shake-up, analysts at HSBC said in a note to clients downgrading their rating of the healthcare ...

In a surprise announcement last week, UnitedHealth Group revealed that Andrew Witty is stepping down as CEO of the health insurance leviathan, citing “personal reasons” for his departure. Before Witty ...

UnitedHealth Group has been a reliable megacap for years. Its sudden decline in recent months is raising questions about the future fate of its stock.

The shooting of UnitedHealthcare CEO Brian Thompson in December illustrates the growing consumer outrage towards our entire U ...

The company has said in regulatory filings that investigations, audits and reviews by a dozen different government agencies ...

We're witnessing one of the most dramatic declines by major, well-capitalized stocks in recent memory. Health insurance giant ...

Stephen Hemsley hasn't been CEO at UnitedHealth Group in nearly a decade yet he's never really left. Since that day, the company's stock has fallen from $610 a share to $308 on Tuesday, an ...

UnitedHealth is almost as oversold as during the Great Financial Crisis, with its monthly RSI sitting at 33. Find out why UNH ...

The DOJ criminal probe concerns the company's billing practices in its Medicare Advantage unit for older adults and people ...

The health care giant's shares are down more than 50% in the last month. That's hurting the powerful U.S. stock-market index.

UnitedHealth shares dropped 55%, facing lawsuits and claim rejection issues. Management changes raise questions on recovery.

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.